CRSPHealthcare · Biotechnology
CRISPR Therapeutics
DeepValues Research covers CRISPR Therapeutics (CRSP) with 1 research report since Sep 23, 2026. The latest Deep Value Intelligence report (Sep 23, 2026) ends with a Neutral stance (2.30/5). Sector: Healthcare · Biotechnology.
Research timeline
-
Deep Value Intelligence
CRISPR Therapeutics (CRSP) Deep Value Intelligence ReportNeutral (2.30/5) on CRISPR Therapeutics (CRSP), Sep 23, 2026. Price $56. CRISPR Therapeutics AG, ticker CRSP, is a high-risk biotechnology company with…
Compare with other Healthcare companies
All Healthcare stocks| Company | Latest stance | Reports |
|---|---|---|
| CRSPCRISPR Therapeutics | Neutral2.30 | 1 |
| ALLOAllogene Therapeutics | Bearish3.10 | 1 |
| MRNA | Neutral3.01 | 1 |
| INSMInsmed | Bearish2.52 | 1 |
| GMABGenmab A/S | Bearish4.01 | 1 |
| MNKDMannKind | Neutral2.63 | 1 |
| TPSTTempest Therapeutics | Bearish2.65 | 1 |
| ADMAADMA Biologics | Neutral3.37 | 1 |
| LENZLENZ Therapeutics | Bearish3.12 | 1 |
Charts from the latest report
Open report
